Posted in | News | Renewable Energy | Wind Power

OGE Energy Corp to Generate 227MW from Crossroads Wind Farm

OGE Energy Corp (OG&E) has recently reached an undisputed agreement with its clients and share holders, administrative units of the state, and regulatory authorities to construct and operate a new wind farm in northwestern part of Oklahoma.

This new wind farm called ‘Crossroads’ has received the approval of the Oklahoma Corporation Commission to build a 227MW project.

Crossroads wind farm, to come up in Dewey County near Canton, is expected to be built by Renewable Energy Systems Americas Inc. RES America is planning to install 86 Siemens turbines with a rated capacity of 2.3MW each and connect the generated power to OG&E's new Wind speed power transmission line, located near Oklahoma City. Initially OG&E is planning to generate 198MW renewable energy from the wind farm, and connect it to the grid. During the initial years of power production clients may find 59 to 65 cents increase in their monthly bills, which will eventually start reducing from the beginning of the year 2013 or 2014 and continue to reduce every year till the wind farm continues to operate.

Currently OG&E produces 270MW wind power and is planning to achieve 550MW power capacity this year, with the completion of other projects currently under construction. The completion of Crossroads project will allow the company to generate a total of 750MW of wind power which constitutes nearly 10% of OG&E’s total power production capability which includes coal and natural gas. Currently OG&E provides electric power supply to approximately 779,000 customers living 30,000 square miles of Oklahoma and Western Arkansas.

Source: http://www.oge.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.